期刊文献+

β受体阻滞剂对高血压并冠心病患者血栓形成影响分析

下载PDF
导出
摘要 目的:探讨和研究治疗高血压并冠心病患者时,采用β受体阻滞剂对患者血栓形成的影响。方法选择2013年1月~2014年6月在我院接受治疗的120例高血压并冠心病患者为研究对象,将所有患者分为对照组和观察组,每组60例,对照组采用常规治疗方式,观察组在常规治疗基础上采用β受体阻滞剂(以美托洛尔为例)。结果观察组患者形成血栓几率为18.33%(11/60),粥样斑块稳定率为83.33%(50/60),对照组患者形成血栓几率为31.67%(19/60),粥样斑块稳定率为68.33%(41/60),比较差异均具有统计学意义(P<0.05)。结论β受体阻滞剂对高血压并冠心病患者血栓形成影响重大,临床效果显著,在治疗高血压并冠心病患者中值得推广和借鉴。
出处 《医学信息(医学与计算机应用)》 2014年第33期247-247,共1页 Medical Information
  • 相关文献

参考文献5

二级参考文献41

  • 1李雷,夏勇,李东野,杨煜,张超群,潘德峰,张延斌.血浆血管性血友病因子水平与冠状动脉病变的关系[J].心血管康复医学杂志,2007,16(3):252-254. 被引量:3
  • 2James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults re- port from the panel members appointed to the eighth joint nation- al committee (JNCS)[J]. JAMA,2014,3"11(5) :507-520.
  • 3Gifford RW Jr. The 1984 JNC report on hypertension (joint na- tional committee on detection, evaluation, and treatment of high blood pressure)[J]. Cleve Clin Q,1984,51(3):515-516.
  • 4The }i{th report of the ioint national committee on detection, eval- uation, and treatment of high blood pressure(JNCV )[J]. Arch Intern Med,1993,153(2) : 154-183.
  • 5Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure[J]. Hypertension, 2003,42 (6) 1206-1252.
  • 6Dahl6 f B, Devereux RB, Kjeldsen SE, et al. Cardiovascular mor- bidity and mortality in the losartan intervention for endpoint re- duction in hypertension study (LIFE) : a randomised trial against atenolol[J]. Lancet,2002,359(9311) ..995-1003.
  • 7Wikstrand J. Primary prevention in patients with hypertension, comments on the clinical implications of the MAPHY study. Metoprolol atherosclerosis prevention in hypertensives study[J]. Am Heart J,1988,116(1 Pt 2):338-347.
  • 8Dahl6f B, Sever PS, Poulter NR, et al. Prevention of cardiovas- cular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflu- methiazide as required, in the Anglo-Scandinavian cardiac out- comes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial [ J ]. Lancet, 2005, 366 (9489) :895-906.
  • 9Wilhelmsen L, Berglund G, Elmfeldt D, et al. Beta-blockers ver-sus diuretics in hypertensive men: main results from the HAPPHY trial[J]. J Hypertens, 1987,5(5) 561-572.
  • 10The IPPPSH collaborative group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-bloc- ker oxprenolol: the international prospective primary prevention study in hypertension (IPPPSH) [J]. J Hypertens, 1985,3 (4) 379-392.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部